NCT06885411 Ototoxicity in Patients With MoM Hip Bearings
| NCT ID | NCT06885411 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Reinier Haga Orthopedisch Centrum |
| Condition | Ototoxic Hearing Loss |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-02-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2023-02-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn about ototoxicity in patients with a MoM hip arthroplasty. The main question it aims to answer is: • What is the prevalence of hearing loss in patients with high and low plasma metal concentrations.
Eligibility Criteria
Inclusion Criteria: * all MoM patients from the different clinics * revision MoM * willing to participate * speak/write the Dutch language Exclusion Criteria: * Not willing to participate * previous ENT surgery or ENT pathology
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06885411 clinical trial?
This trial is open to participants of all sexes, studying Ototoxic Hearing Loss. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06885411 currently recruiting?
Yes, NCT06885411 is actively recruiting participants. Contact the research team at n.mathijssen@rhoc.nl for enrollment information.
Where is the NCT06885411 trial being conducted?
This trial is being conducted at Delft, Netherlands.
Who is sponsoring the NCT06885411 clinical trial?
NCT06885411 is sponsored by Reinier Haga Orthopedisch Centrum. The trial plans to enroll 200 participants.